Efficacy and Safety of RTX-GRT7039 in Adult Subjects With Knee Osteoarthritis
Status:
Not yet recruiting
Trial end date:
2024-02-01
Target enrollment:
Participant gender:
Summary
A double-blind, randomized, placebo-controlled, parallel-group, multi-site, clinical trial to
confirm the efficacy and safety of repeated injections of RTX-GRT7039 versus placebo in
patients who have pain associated with osteoarthritis of the knee despite standard of care.